NCT05609656 2024-06-03
ELI
Zealand University Hospital
Phase 2 Terminated
Clinical Trials
7 trialsNCT05435053 2023-09-15
CHECKPOINT
Zealand University Hospital
Phase 2 Terminated
NCT03823131 2023-05-09
Optimizing Antitumor Immunity Using Plasmid Electroporation, Pembrolizumab, and Epacadostat
University of California, San Francisco
Phase 2 Terminated
NCT02926040 2020-02-27
IRE Qol
Insel Gruppe AG, University Hospital Bern
Terminated
NCT02952859 2020-02-26
IRE Marg
Insel Gruppe AG, University Hospital Bern
Terminated
NCT03069599 2020-02-26
IRE Immuno
Insel Gruppe AG, University Hospital Bern
Terminated
NCT02787954 2018-10-18
Liver
The University of Texas Health Science Center, Houston
Terminated